Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223
Awaiting development [GID-HST10019] Expected publication date: TBC
Awaiting development [GID-HST10019] Expected publication date: TBC
Awaiting development [GID-HST10049] Expected publication date: TBC
Awaiting development [GID-HST10022] Expected publication date: TBC
Awaiting development [GID-HST10039] Expected publication date: TBC
Awaiting development [GID-HST10020] Expected publication date: TBC
Awaiting development [GID-HST10032] Expected publication date: TBC
Awaiting development [GID-HST10046] Expected publication date: TBC
We are listening to your views on this Interventional procedures guidance. Comments close 24 May 2022.
Awaiting development [GID-IPG10249] Expected publication date: TBC
Awaiting development [GID-IPG10250] Expected publication date: TBC
Awaiting development [GID-IPG10251] Expected publication date: TBC
Awaiting development [GID-IPG10248] Expected publication date: TBC
Awaiting development [GID-IPG10247] Expected publication date: TBC
Awaiting development [GID-IPG10235] Expected publication date: TBC
Awaiting development [GID-IPG10205] Expected publication date: TBC
Awaiting development [GID-IPG10220] Expected publication date: 16 November 2022
Awaiting development [GID-IPG10216] Expected publication date: 21 April 2023
Awaiting development [GID-IPG10236] Expected publication date: 29 June 2023